FDA approves Bayer drug for rare gastrointestinal tract cancer
February 25, 2013 at 14:06 PM EST
WASHINGTON, Feb 25 (Reuters) - The U.S. Food and Drug Administration said on Monday it has approved Bayer AG's drug Stivarga for the treatment of a rare type of gastrointestinal tract cancer.
